Skip to main content
Clinical Trials/IRCT20130428013159N12
IRCT20130428013159N12Not yet recruitingPhase 3

A clinical trial to compare the effectiveness of glargine insulin and regular insulin in hyperglycemic control among type II diabetic patients undergoing on-pump coronary artery bypass graft before, during, and after the operation

Mashhad University of Medical Sciences0 sites80 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
Phase 3
Status
Not yet recruiting
Enrollment
80

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
35 years to 65 years (—)
Sex
All

Inclusion Criteria

  • Age of 35-65 years
  • Sustaining ASA II
  • Blood sugar of 150-350 mg/dl
  • Lack of a simultaneous emergency surgery or heart valve surgery

Exclusion Criteria

  • Having underlying diseases (e.g., pulmonary, liver, kidney, thyroid, and digestive diseases)
  • Having history of open-heart surgery
  • Carotid artery involvement
  • Sensitivity to insulin glargine

Investigators

Similar Trials